Fri, November 4, 2022
Thu, November 3, 2022
Wed, November 2, 2022

Timothy Chiang Initiated (AKYA) at Buy and Held Target at $19 on, Nov 3rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-19-on-nov-3rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Timothy Chiang of Capital One, Initiated "Akoya Biosciences, Inc." (AKYA) at Buy and Held Target at $19 on, Nov 3rd, 2022.

Timothy has made no other calls on AKYA in the last 4 months.



There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with Timothy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Timothy


  • Mason Carrico of "Stephens & Co." Initiated at Buy and Held Target at $16 on, Thursday, October 6th, 2022
  • David Westenberg of "Piper Sandler" Maintained at Buy with Increased Target to $17 on, Wednesday, August 17th, 2022

Publication Contributing Sources